The group used percentage change in tumour vascularity (as measured by total haemoglobin on near infrared imager coupled with US) to predict pCR with an AUC of 0.96 in HER2-positive tumours and 0.95 irrespective of subtype, although this was a relatively small study of 22 patients. This evidence concerns the gene ERBB2 and neoplasm.